Skip to content
FDA drug shortage status

Is Emtricitabine Oral Solution (Emtriva) in shortage?

Emtricitabine Oral Solution is listed by FDA as being discontinued by at least one maker (updated Jun 17, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1)
    Gilead Sciences, Inc.Being discontinuedUpdated Jun 17, 2026Discontinued Jun 17, 2026

    Product expected to be available until March 2027

    Maker contact: 800-445-3235

FDA recalls of Emtricitabine

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Emtricitabine Oral Solution:

Other forms on FDA’s list

Emtricitabine Oral Solution shortage questions

Is Emtricitabine Oral Solution (Emtriva) in shortage?

Emtricitabine Oral Solution is listed by FDA as being discontinued by at least one maker (updated Jun 17, 2026).

What should I do if I can’t get Emtricitabine Oral Solution?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.